Delivery Order SPE2DB22D2206-SPE2DB25FKB74
- Not listed
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract that represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. The contract carries a ceiling value of $9,438.70 under firm fixed price terms, with an ultimate completion date of October 16, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical distributor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $4,745.80 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (14-count) on August 26, 2025, with completion scheduled for September 17, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract contains no set-aside designation and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (quantity: 7 units). This non-set-aside competitive award was executed on September 22, 2025, with an ultimate completion date of October 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB74Delivery Order
The Defense Logistics Agency awarded a $9.44K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Prevymis 480 mg tablets (7-count units), with completion targeted for October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This award reflects AmerisourceBergen's established role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain. The company's $1 billion IDC with DLA Troop Support Medical serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and other medical supplies to support military healthcare programs worldwide. Prevymis, an antiviral medication used primarily for cytomegalovirus prevention in transplant recipients, represents one of the specialized pharmaceutical commodities within the company's expansive federal contract portfolio, demonstrating its capability to fulfill diverse and specialized medical supply requirements for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/24/25 |